🕵️ Abbott Laboratories ($ABT)
SEC insider & ownership activity, last 12 months · CIK 1800 · every row links its SEC filing
Over the last 12 months insiders sold $1.4M against $4.4M of open-market buying. Robert B. Ford bought $2.0M in discretionary trades (Jan). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
4 buyers, $4.4M (6 lots) · 7 sellers, $1.4M (8 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Robert B. Ford | 1 | $2.0M | 0 | – | Jan 23, 2026 |
| Daniel J. Starks | 3 | $2.0M | 0 | – | Apr 27, 2026 |
| Philip P. Boudreau | 1 | $201K | 1 | $747K | Apr 23, 2026 |
| Eric Shroff | 0 | – | 2 | $285K | Mar 2, 2026 |
| John G. Stratton | 1 | $174K | 0 | – | May 7, 2026 |
| Louis H. Morrone | 0 | – | 1 | $132K | Mar 2, 2026 |
| Daniel Gesua Sive Salvadori | 0 | – | 1 | $102K | Mar 2, 2026 |
| Mary K. Moreland | 0 | – | 1 | $71K | Mar 2, 2026 |
| JOHN A. McCoy, JR. | 0 | – | 1 | $68K | Mar 2, 2026 |
| Elizabeth C. Cushman | 0 | – | 1 | $30K | Mar 2, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Vanguard Capital Management | 7.5% | 13G | Apr 29, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Robert J. Alpern | $647K | May 15, 2026 | filing ↗ |
| Robert J. Alpern | $2.7M | Apr 27, 2026 | filing ↗ |
| Elizabeth C. Cushman | $30K | Mar 2, 2026 | filing ↗ |
| Eric Shroff | $82K | Mar 2, 2026 | filing ↗ |
| Louis H. Morrone | $132K | Mar 2, 2026 | filing ↗ |
| Mary K. Moreland | $71K | Mar 2, 2026 | filing ↗ |
| JOHN A. McCoy, JR. | $68K | Mar 2, 2026 | filing ↗ |
| Daniel Gesua Sive Salvadori | $102K | Mar 2, 2026 | filing ↗ |
| Eric Shroff | $203K | Nov 25, 2025 | filing ↗ |
| Philip P. Boudreau | $747K | Aug 8, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Jul 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 16, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 24, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Apr 24, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 24, 2026 | filing ↗ |
| Earnings (2.02) | Apr 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 16, 2026 | filing ↗ |
| Other events (8.01) | Apr 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 10, 2026 | filing ↗ |
| Other events (8.01) | Mar 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 9, 2026 | filing ↗ |
| New financial obligation (2.03) | Mar 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 9, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 23, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Feb 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 20, 2026 | filing ↗ |
| Earnings (2.02) | Jan 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 22, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 12, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Dec 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 12, 2025 | filing ↗ |
| Material agreement (1.01) | Nov 19, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 19, 2025 | filing ↗ |
| Other events (8.01) | Nov 19, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 19, 2025 | filing ↗ |
| Temporary Suspension of Trading Under Registrant's Employee Benefit Plans (5.04) | Nov 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 18, 2025 | filing ↗ |